Clinical Trial 35928

Oakland, CA 94607


Study Summary:

To evaluate the efficacy and safety of adjunctive pimavanserin compared with adjunctive placebo in the treatment of schizophrenia.


Qualified Participants Must:

• Be 18 years of age and older (Adult, Senior)
• Have a clinical diagnosis of schizophrenia with a minimum duration of 1 year
• Live within 100 miles of the study location (within the greater Los Angeles area)


Qualified Participants May Receive:

Qualified participants may receive compensation for time and travel. for more information on compensation please contact CNS.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.